Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The "inclusion benefit" in clinical trials.

Lantos JD.

J Pediatr. 1999 Feb;134(2):130-1. No abstract available.

PMID:
9931513
2.

[Measuring errors in neonatal randomized controlled trials. Deficient quality concerning the informed consent].

Finnström O.

Lakartidningen. 2001 May 16;98(20):2474-5. Swedish. No abstract available.

PMID:
11433980
3.

Ethics committees and informed consent: locating responsibility in clinical trials.

Crawley FP.

Tokai J Exp Clin Med. 1997 Dec;22(6):259-65. Review. No abstract available.

PMID:
9670424
4.
5.

Is informed consent always necessary for randomized, controlled trials?

Tenery RM Jr.

N Engl J Med. 1999 Aug 5;341(6):450. No abstract available.

PMID:
10438266
6.

Obtaining informed consent for neonatal randomised controlled trials--an "elaborate ritual"?

Mason S.

Arch Dis Child Fetal Neonatal Ed. 1997 May;76(3):F143-5. No abstract available.

7.

Ethics of clinical trials.

Rosenzweig S.

N Engl J Med. 2000 Mar 30;342(13):979; author reply 979-80. No abstract available.

PMID:
10744499
8.

Ethics of clinical trials.

Butow PN, Brown RF, Tattersall MH.

N Engl J Med. 2000 Mar 30;342(13):978; author reply 979-80. No abstract available.

9.

[What medical data should be reported to clinical trial partici- pants?].

Kaste M.

Duodecim. 1989;105(22):1877-82. Finnish. No abstract available.

PMID:
2598851
10.

Placebo-controlled trials.

Markman M.

Ann Intern Med. 2001 Jul 3;135(1):63-4. No abstract available.

PMID:
11434741
11.

Assessment, ethics, and the randomized controlled trial.

Baum M.

Int J Technol Assess Health Care. 1989;5(3):305-8. No abstract available.

PMID:
10295518
12.

Dealing with the unknown: reducing the proportion of unvalidated treatments offered to children.

Wilkinson D, Chalmers I, Cruz M, Tarnow-Mordi W.

Arch Dis Child Fetal Neonatal Ed. 2015 May;100(3):F190-2. doi: 10.1136/archdischild-2014-306313. Epub 2015 Feb 18. No abstract available.

PMID:
25693598
13.

Adaptive designs, informed consent, and the ethics of research.

Pullman D, Wang X.

Control Clin Trials. 2001 Jun;22(3):203-10.

PMID:
11384785
14.

Ethical issues in the design and conduct of randomised controlled trials.

Edwards SJ, Lilford RJ, Braunholtz DA, Jackson JC, Hewison J, Thornton J.

Health Technol Assess. 1998 Dec;2(15):i-vi, 1-132. Review. No abstract available.

15.

Informed consent. Subjects may not understand concept of clinical trials.

Elbourne D, Snowdon C, Garcia J.

BMJ. 1997 Jul 26;315(7102):248-9. No abstract available.

16.

Beyond randomized, controlled trials.

Dreyfuss D.

Curr Opin Crit Care. 2004 Dec;10(6):574-8. Review.

PMID:
15616404
17.

Ethical issues in placebo-controlled trials in Alzheimer disease.

Hecker JR, Cleland EG, Snellgrove CA.

Med J Aust. 2001 Jan 15;174(2):104-5. No abstract available.

PMID:
11245497
18.

Randomized, placebo-controlled trial.

Al Abdukareem A.

Ann Saudi Med. 2004 Mar-Apr;24(2):145; author reply 145; discussion 145. No abstract available.

19.

Placebo surgery in trials of therapy for Parkinson's disease.

Weiner WJ.

N Engl J Med. 2000 Feb 3;342(5):353; author reply 354-5. No abstract available.

PMID:
10660396
20.

Should we ever do sham operations?

Gillett GR.

J Clin Neurosci. 2001 Mar;8(2):116-9. Review. No abstract available.

PMID:
11484658

Supplemental Content

Support Center